1. Home
  2. |Insights
  3. |PODCAST: Common Misperceptions About Undoing a Prior Administration's Executive Actions — C&M's First 100 Days Series

PODCAST: Common Misperceptions About Undoing a Prior Administration's Executive Actions — C&M's First 100 Days Series

Client Alert | 1 min read | 12.12.16

In the latest podcast for Crowell & Moring’s “First 100 Days” series, Dan Wolff, chair of the firm’s Administrative Law & Regulatory Practice, and Tom Lorenzen, partner in the firm’s Environment & Natural Resources Group and former assistant chief with the DOJ’s Environment & Natural Resources Division, sit down with Jim Flood, chair of Crowell & Moring’s Government Affairs Group, to discuss the possibility of President-elect Trump’s administration repealing, replacing, or eliminating prior executive actions, regulatory actions, or other policies.

Common misperceptions that will be addressed in this 15 minute podcast:

  • A new president can easily strike all the regulations he or she does not like on day one.
  • Regulations promulgated pursuant to Executive Orders can be erased simply by revoking the Executive Order.
  • Congress can simply eliminate regulations under the Congressional Review Act and the new administration can start on a blank slate.
  • Regulations at various stages of finalization can easily be discarded.

Click below to listen or access from one of these links:
PodBean | SoundCloud | iTunes

Contacts

Insights

Client Alert | 2 min read | 09.18.25

FDA Announces Intention to Initiate an Aggressive Enforcement Campaign Against Misleading Pharmaceutical Advertising

On September 9, 2025, the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (HHS) issued a news release announcing an “aggressive[]” “crackdown” on direct-to-consumer pharmaceutical advertising. This release came on the heels of a Presidential Memorandum President Trump issued the same day directing HHS to “ensure transparency and accuracy in direct-to-consumer prescription drug advertisements,” and the FDA to “take action to enforce legal requirements that advertisements for prescription drugs be truthful and not misleading.”...